MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202423100247 A) filed by Zenvision Pharma LLP on December 18, 2024, for Nasal Drug Delivery System Of Brivaracetam Or Salt Thereof.
Inventors include Bobba Venkata Sivakumar; Jadhav Bhimrao; and Shinde Dhananjay.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present disclosure relates to the intranasal drug delivery system or composition of Brivaracetam or salt thereof. The nasal drug delivery Brivaracetam or salt thereof preferably in the form of Nasal sprays provide more bioavailability better onset of action, lesser adverse effects; better ease of self-administration and better patient compliance in the treatment of partial-onset seizures.
Disclaimer: Curated by HT Syndication.
